159 related articles for article (PubMed ID: 19406231)
61. Polyhydroxybutyrate-coated magnetic nanoparticles for doxorubicin delivery: cytotoxic effect against doxorubicin-resistant breast cancer cell line.
Yalcin S; Unsoy G; Mutlu P; Khodadust R; Gunduz U
Am J Ther; 2014; 21(6):453-61. PubMed ID: 25137407
[TBL] [Abstract][Full Text] [Related]
62. Halobetasol propionate-loaded solid lipid nanoparticles (SLN) for skin targeting by topical delivery.
Bikkad ML; Nathani AH; Mandlik SK; Shrotriya SN; Ranpise NS
J Liposome Res; 2014 Jun; 24(2):113-23. PubMed ID: 24131382
[TBL] [Abstract][Full Text] [Related]
63. Development, characterization and evaluation of doxorubicin nanostructured lipid carriers for prostate cancer.
Zhang HW; Dang Q; Zhang ZW; Wu FS
J BUON; 2017; 22(1):102-111. PubMed ID: 28365942
[TBL] [Abstract][Full Text] [Related]
64. Tumor-preferential sustained drug release enhances antitumor activity of block copolymer micelles.
Ponta A; Bae Y
J Drug Target; 2014 Aug; 22(7):619-28. PubMed ID: 24766185
[TBL] [Abstract][Full Text] [Related]
65. Characterization and formulation optimization of solid lipid nanoparticles in vitamin K1 delivery.
Liu CH; Wu CT; Fang JY
Drug Dev Ind Pharm; 2010 Jul; 36(7):751-61. PubMed ID: 20136495
[TBL] [Abstract][Full Text] [Related]
66. Study of solid lipid nanoparticles with respect to particle size distribution and drug loading.
Patravale VB; Ambarkhane AV
Pharmazie; 2003 Jun; 58(6):392-5. PubMed ID: 12857001
[TBL] [Abstract][Full Text] [Related]
67. Mannosylated solid lipid nanoparticles as vectors for site-specific delivery of an anti-cancer drug.
Jain A; Agarwal A; Majumder S; Lariya N; Khaya A; Agrawal H; Majumdar S; Agrawal GP
J Control Release; 2010 Dec; 148(3):359-67. PubMed ID: 20854859
[TBL] [Abstract][Full Text] [Related]
68. Bedaquiline-Loaded Solid Lipid Nanoparticles Drug Delivery in the Management of Non-Small-Cell Lung Cancer (NSCLC).
Najib Ullah SNM; Afzal O; Altamimi ASA; Alossaimi MA; Almalki WH; Alzahrani A; Barkat MA; Almeleebia TM; Alshareef H; Shorog EM; Khan G; Singh T; Singh JK
Pharmaceuticals (Basel); 2023 Sep; 16(9):. PubMed ID: 37765117
[TBL] [Abstract][Full Text] [Related]
69. Functionalized dextran-coated liposomes for doxorubicin loading.
Ning S; Huang Q; Li J; Zhang Y; Liu YN
J Control Release; 2011 Nov; 152 Suppl 1():e49-51. PubMed ID: 22195919
[No Abstract] [Full Text] [Related]
70. Preparation of solid lipid nanoparticles with clobetasol propionate by a novel solvent diffusion method in aqueous system and physicochemical characterization.
Hu FQ; Yuan H; Zhang HH; Fang M
Int J Pharm; 2002 Jun; 239(1-2):121-8. PubMed ID: 12052697
[TBL] [Abstract][Full Text] [Related]
71. Doxorubicin and MBO-asGCS oligonucleotide loaded lipid nanoparticles overcome multidrug resistance in adriamycin resistant ovarian cancer cells (NCI/ADR-RES).
Siddiqui A; Gupta V; Liu YY; Nazzal S
Int J Pharm; 2012 Jul; 431(1-2):222-9. PubMed ID: 22562053
[TBL] [Abstract][Full Text] [Related]
72. Hollow core-porous shell structure poly(acrylic acid) nanogels with a superhigh capacity of drug loading.
Chen Y; Zheng X; Qian H; Mao Z; Ding D; Jiang X
ACS Appl Mater Interfaces; 2010 Dec; 2(12):3532-8. PubMed ID: 21080640
[TBL] [Abstract][Full Text] [Related]
73. Buparvaquone loaded solid lipid nanoparticles for targeted delivery in theleriosis.
Soni MP; Shelkar N; Gaikwad RV; Vanage GR; Samad A; Devarajan PV
J Pharm Bioallied Sci; 2014 Jan; 6(1):22-30. PubMed ID: 24459400
[TBL] [Abstract][Full Text] [Related]
74. Assessment of doxorubicin delivery devices based on tailored bare polycaprolactone against glioblastoma.
Niza E; Castro-Osma JA; Posadas I; Alonso-Moreno C; Bravo I; Garzón A; Canales-Vázquez J; Ceña V; Lara-Sánchez A; Albaladejo J; Otero A
Int J Pharm; 2019 Mar; 558():110-119. PubMed ID: 30639216
[TBL] [Abstract][Full Text] [Related]
75. Solid lipid nanoparticles for delivery of Calendula officinalis extract.
Arana L; Salado C; Vega S; Aizpurua-Olaizola O; Arada I; Suarez T; Usobiaga A; Arrondo JLR; Alonso A; Goñi FM; Alkorta I
Colloids Surf B Biointerfaces; 2015 Nov; 135():18-26. PubMed ID: 26231862
[TBL] [Abstract][Full Text] [Related]
76. A simple one-step protocol for preparing small-sized doxorubicin-loaded liposomes.
Sonar S; D'Souza SE; Mishra KP
J Environ Pathol Toxicol Oncol; 2008; 27(3):181-9. PubMed ID: 18652565
[TBL] [Abstract][Full Text] [Related]
77. Effect of PEG2000 on drug delivery characterization from solid lipid nanoparticles.
Hong Y; Hu FQ; Yuan H
Pharmazie; 2006 Apr; 61(4):312-5. PubMed ID: 16649544
[TBL] [Abstract][Full Text] [Related]
78. Preparation of solid lipid nanoparticles by a solvent emulsification-diffusion technique.
Trotta M; Debernardi F; Caputo O
Int J Pharm; 2003 May; 257(1-2):153-60. PubMed ID: 12711170
[TBL] [Abstract][Full Text] [Related]
79. Nanoparticles generated from a tryptophan derivative: physical characterization and anti-cancer drug delivery.
Dube T; Mandal S; Panda JJ
Amino Acids; 2017 May; 49(5):975-993. PubMed ID: 28283907
[TBL] [Abstract][Full Text] [Related]
80. Preparation, in vitro release, and pharmacokinetics in rabbits of lyophilized injection of sorafenib solid lipid nanoparticles.
Zhang H; Zhang FM; Yan SJ
Int J Nanomedicine; 2012; 7():2901-10. PubMed ID: 22787390
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
